Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
Francis X. McCormack(University of Cincinnati), Bruce C. Trapnell(Cincinnati Children's Hospital Medical Center), Charlie Strange(Medical University of South Carolina), Hilary J. Goldberg(Harvard University), L.G. Singer(University Health Network), Kevin K. Brown(Health Protection Surveillance Centre), Joel Moss(National Heart Lung and Blood Institute), Mark Brantly(University of Florida), Thomas V. Colby(Mayo Clinic in Arizona), Koh Nakata(Niigata University Medical and Dental Hospital), Gregory P. Downey(National Jewish Health), Hye Seung Lee(Center for Drug Evaluation and Research), Jeffrey T. Chapman(Cleveland Clinic), Angelo M. Taveira‐DaSilva(National Heart Lung and Blood Institute), Jeffrey P. Krischer(University of South Florida), Leslie Korbee(Cincinnati Children's Hospital Medical Center), Roy T. McKay(University of Cincinnati), Alan F. Barker, James Stocks(The University of Texas Health Science Center at Tyler), Joseph P. Lynch(Geisinger Neuroscience Institute), Brent W. Kinder(University of Cincinnati), Eugene J. Sullivan(Insmed (United States)), Yoshikazu Inoue(Fukujuji Hospital), Marsha M. Cohen(University of Toronto), Lisa R. Young(Children's Hospital of Philadelphia)
Cited by 1,115
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2020|1k